Third-party type 2 innate lymphoid cells prevent and treat GI tract GvHD.

Bruce, Danny W; Kolupaev, Oleg; Laurie, Sonia J; Bommiasamy, Hemamalini; Stefanski, Heather; Blazar, Bruce R; Coghill, James M; Serody, Jonathan S

Bruce, Danny W; Kolupaev, Oleg; Laurie, Sonia J; Bommiasamy, Hemamalini; Stefanski, Heather; Blazar, Bruce R; Coghill, James M; Serody, Jonathan S.

Afiliação

Bruce DW; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC.
Kolupaev O; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC.
Laurie SJ; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC.
Bommiasamy H; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC.
Stefanski H; Department of Pediatrics, University of Minnesota Cancer Center, Minneapolis, MN.
Blazar BR; Department of Pediatrics, University of Minnesota Cancer Center, Minneapolis, MN.
Coghill JM; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC.
Serody JS; Department of Medicine; and.

Blood Adv ; 5(22): 4578-4589, 2021 11 23.

Article em En | MEDLINE | ID: mdl-34619767

Assuntos

Doença Enxerto-Hospedeiro; Transplante de Células-Tronco Hematopoéticas; Trato Gastrointestinal; Doença Enxerto-Hospedeiro/prevenção & controle; Transplante de Células-Tronco Hematopoéticas/efeitos adversos; Humanos; Imunidade Inata; Linfócitos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Doença Enxerto-Hospedeiro Limite: Humans Idioma: En Revista: Blood Adv Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Nova Caledônia País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google